InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-11.9%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Kronenfeld Mark A., Director. Insider active across 1 company, notably Pacira BioSciences, Inc.. Cumulatively, 6 disclosures have been recorded. Activity tracked since 9 June 2021. The latest transaction was disclosed on 12 June 2024 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations6 total
5,230 shares0Common StockSEC:0001396814-24-000072:0
1,775 shares0Common StockSEC:0001209191-23-038024:0
15,000 shares@ US$29.90100.0% of flowCommon StockSEC:0001209191-23-036270:0
1,160 shares0Common StockSEC:0001209191-22-035224:0
1,066 shares0Common StockSEC:0001209191-21-040085
1,066 shares0Common StockSEC:0001209191-21-040085:0
6 of 6 declarations
About Kronenfeld Mark A.
Mark A. Kronenfeld is a Director at Pacira BioSciences, Inc., a biopharmaceutical company focused on developing therapeutic solutions. As a board member, he contributes to the company's strategy and oversight of its operations, ensuring that shareholder interests are protected.
